BioMedNewsBreaks - April 16th 2021

CNS Pharmaceuticals Inc.'s (NASDAQ: CNSP) WP1244 Potentially 500X More Potent than Daunorubicin

https://www.biomedwire.com/market-research/?qmtab=fullnews_qmsymbol=CNSP&qmodStoryID=5911316113589730

This could be a HUGE Catalyst for a Major Move in CNSP: NASDAQ on Monday at the open!

This is the time to buy! The float of CNSP is under 25 Million Shares, so Hoping CNSP Halts & Opens Monday at $50!